Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 19, 2022

SELL
$0.42 - $1.48 $4,545 - $16,018
-10,823 Reduced 3.16%
332,004 $488,000
Q1 2022

Apr 26, 2022

SELL
$1.06 - $2.68 $4,243 - $10,728
-4,003 Reduced 1.15%
342,827 $394,000
Q4 2021

Feb 14, 2022

SELL
$2.5 - $5.19 $242,920 - $504,301
-97,168 Reduced 21.88%
346,830 $867,000
Q3 2021

Nov 12, 2021

BUY
$4.82 - $8.46 $182,297 - $319,965
37,821 Added 9.31%
443,998 $2.27 Million
Q2 2021

Aug 13, 2021

BUY
$6.81 - $9.71 $821,388 - $1.17 Million
120,615 Added 42.24%
406,177 $3.38 Million
Q1 2021

May 17, 2021

BUY
$7.45 - $12.32 $2.13 Million - $3.52 Million
285,562 New
285,562 $2.49 Million

About Epizyme, Inc.


  • Ticker EPZM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 168,364,992
  • Market Cap $247M
More about EPZM
Track This Portfolio

Track Hennion & Walsh Asset Management, Inc. Portfolio

Follow Hennion & Walsh Asset Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hennion & Walsh Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hennion & Walsh Asset Management, Inc. with notifications on news.